Evidence map›Paper›PMID 39728819›Full record

ReviewTropical medicine and infectious disease2024

Evolving Landscape of Sickle Cell Anemia Management in Africa: A Critical Review.

Hazel W Musuka, Patrick Gad Iradukunda, Oscar Mano, Eric Saramba, Pierre Gashema, Enos Moyo, Tafadzwa Dzinamarira

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hazel W MusukaSchool of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen AB25 2ZR, UK.
Patrick Gad IradukundaRwanda Food and Drug Authority, Kigali 3243, Rwanda.ORCID 0000-0002-0236-7776
Oscar ManoDepartment of Medical Laboratory Sciences, University of Zimbabwe, Harare 263, Zimbabwe.ORCID 0009-0001-9670-4939
Eric SarambaCollege of Medicine and Health Sciences, University of Rwanda, Kigali 3286, Rwanda.ORCID 0009-0003-3527-0262
Pierre GashemaCollege of Medicine and Health Sciences, University of Rwanda, Kigali 3286, Rwanda.ORCID 0000-0001-9348-0936
Enos MoyoSchool of Nursing and Public Health, Faculty of Medicine and Health Sciences, University of KwaZulu Natal, Durban 4000, South Africa.ORCID 0000-0002-1827-9551
Tafadzwa DzinamariraSchool of Health Systems & Public Health, University of Pretoria, Pretoria 0028, South Africa.ORCID 0000-0002-9929-5739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sickle cell disease (SCD) is a prevalent inherited blood disorder, particularly affecting populations in Africa. This review examined the disease's burden, its diverse clinical presentations, and the challenges associated with its management in African settings. Africa bears a significant burden of SCD, with prevalence varying across countries and age groups. Newborn screening programs have highlighted the high prevalence of SCD at birth, emphasizing the need for early diagnosis and intervention. The clinical manifestations of SCD in Africa are multifaceted, encompassing acute complications like vaso-occlusive crises, acute chest syndrome, and stroke, as well as chronic complications such as organ damage and leg ulcers. Biological factors, including fetal hemoglobin levels, and demographic factors, like age and sex, influence disease severity and outcomes. The management of SCD in Africa faces numerous challenges. Limited access to resources, including diagnostic tools, medications, and trained healthcare professionals, hinders optimal care. The high cost of advanced therapies further restricts patient access. Cultural stigma and a lack of awareness create additional barriers to effective management. To address these challenges, early diagnosis through newborn screening programs and point-of-care testing is crucial. Comprehensive care models, including hydroxyurea therapy, pain management, and patient education, are essential for improving outcomes. Collaboration with international networks and leveraging local resources can enhance the sustainability of SCD programs. In conclusion, SCD significantly impacts African populations. Overcoming the challenges associated with its management requires addressing resource limitations, affordability issues, and cultural barriers. Early diagnosis, comprehensive care models, and ongoing research focused on affordability and accessibility are crucial for improving the lives of individuals living with SCD in Africa.

Indexed as

Africadisease managementsickle cell disease

Identifiers

PMID39728819
PMCPMC11680351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.